It was shown in vivo that CTGF-knockout in mouse fibroblasts resulted in reduced neovascularization induced by the tumor, which was additionally confirmed by a decreased level of endothelial marker CD31/platelet endothelial cell adhesion molecule (PECAM-1) within the tumor and its stroma. Here, CCN2 is linked to neoplasm.